Pbyi stock price target

PBYI - Puma Biotechnology Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Puma Biotechnology stock price target cut to $23 from $83 at J.P. Morgan MarketWatch. More. Company Releases for Puma Biotechnology Inc. Thursday, April 02, 2020. Here's Why Puma Biotechnology Tumbled Today | The Motley Fool Oct 08, 2019 · In an unrelated move, Goldman Sachs analyst Paul Choi downgraded Puma Biotechnology stock from neutral to sell, changed the price target from …

The median PBYI price target (a different metric than the average or mean) was $14.5 as of 2020-03-17, the highest PBYI price target in the range was $24.0 while the lowest PBYI price target in the range was $9.0, with a standard deviation of $4.929. Get the latest Zacks research report on PBYI — FREE. 10 ETFs With Most Upside To Analyst Targets Puma Biotechnology Inc Common Stock (PBYI) Real-Time Stock ... PBYI's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low Puma Biotechnology, Inc. - PBYI - Stock Price Today - Zacks View Puma Biotechnology, Inc. PBYI investment & stock information. Get the latest Puma Biotechnology, Inc. PBYI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Puma Biotechnology Inc. Stock Price (PBYI) | Barron's Nov 08, 2019 · View today's stock price, news and analysis for Puma Biotechnology Inc. (PBYI). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation

Discover historical prices for PBYI stock on Yahoo Finance. View daily, weekly or monthly format back to when Puma Biotechnology Inc stock was issued.

Analysts Have Mixed Ratings On Puma Biotechnology Inc ... Mar 09, 2020 · That day the Cantor Fitzgerald set price target on the stock to $20. The stock was given Mkt Perform rating by Leerink Partners in its report released on January 17, 2019, the day when the price target on the stock was placed at 21. Guggenheim was of a view that PBYI is Neutral in its latest report on January 03, 2019. PBYI | Puma Biotechnology Inc. Analyst Estimates & Rating ... PBYI updated stock price target summary. Dow Jones, a News Corp company. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. Puma Biotechnology Inc (PBYI) Stock Historical Prices ... Discover historical prices for PBYI stock on Yahoo Finance. View daily, weekly or monthly format back to when Puma Biotechnology Inc stock was issued. PBYI Price Target - ETF Channel

Puma Biotechnology (NASDAQ:PBYI) was upgraded by stock analysts at BidaskClub from a “sell” rating to a “hold” rating in a report issued on Saturday, BidAskClub reports. Other research analysts have also recently issued reports about the stock. Guggenheim cut shares of Puma Biotechnology from a “buy” rating to a “neutral” rating in a research note […]

PBYI Share Price Target - Puma Biotechnology Inc NYSE USA ... Puma Biotechnology Inc Share/Stock Price - PBYI NYSE USA Technical Analysis, Target, Important Levels, Latest News, Interactive Charts. Puma Biotechnology Inc (PBYI) Stock Price, Quote, History ... Find the latest Puma Biotechnology Inc (PBYI) stock quote, history, news and other vital information to help you with your stock trading and investing.

Get today's Puma Biotechnology Inc stock price and latest PBYI news as well as Puma Biotech real-time stock quotes, technical analysis, full financials and 

Stock analysis for Puma Biotechnology Inc (PBYI:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Puma Biotechnology, Inc. [PBYI]: Target Price for PBYI is ... Nov 27, 2019 · Analysts estimates state that Puma Biotechnology, Inc. [PBYI] stock could reach median target price of N/A. Puma Biotechnology, Inc. [PBYI] stock additionally went up by +11.31% in the period of the 7 days, recording a gain in performance by 23.68% in the last 30 days. PBYI Stock News and Research Articles | Puma Biotechnology ... PBYI Stock News and Research Articles - Puma Biotechnology : latest news, headlines and research articles. Needham analyst raises target price after promising results of drug trial. Seattle Genetics Inc. (SGEN) CEO Clay Siegall called new data from the study of the company’s breast cancer drug “stunning.”

Puma Biotechnology Stock Price Forecast, PBYI stock price prediction. The best long-term & short-term Puma Biotechnology share price prognosis for 2020, 

Puma Biotechnology Stock Price Forecast, PBYI stock price prediction. The best long-term & short-term Puma Biotechnology share price prognosis for 2020,  Get today's Puma Biotechnology Inc stock price and latest PBYI news as well as Puma Biotech real-time stock quotes, technical analysis, full financials and  Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock? 1 month ago | Simply Wall St. Puma Biotechnology, Inc. (NASDAQ:PBYI):   28 Feb 2020 In a report issued on February 20, RBC Capital also maintained a Hold rating on the stock with a $13.00 price target. See today's analyst top  View today's stock price, news and analysis for Puma Biotechnology Inc. (PBYI). Barron's also provides information on historical stock ratings, target prices,  Real time Puma Biotechnology (PBYI) stock price quote, stock graph, news & analysis. There may be differences between the Equity Summary Score analyst count and the number of underlying analysts listed. Due to the timing in receiving ratings 

There may be differences between the Equity Summary Score analyst count and the number of underlying analysts listed. Due to the timing in receiving ratings  8 Oct 2019 Plus, all seven analysts covering the biotech maintain a "hold" or worse recommendation. However the average 12-month price target sits all the  11 Mar 2020 The stock currently trades at $9.96 and analysts tracking its performance over the next 12 months have a consensus estimate price target of